TriSalus Life Sciences: chief of research Cox Bryan F. sold 296 shares

What happened Cox Bryan F., chief of research, sold 296 shares at $4.39 per share on Oct 5, 2026, for $1,299, according to the Form 4 filed Oct 7, 2026.

Key details

• Transaction date and price: Oct 5, 2026 — sale of 296 shares at $4.39 per share.
• Filing date: Form 4 filed Oct 7, 2026.
• Shares owned after the transaction: not disclosed in the filing.
• Footnote F1: the filing states the shares were sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person and that the transaction does not represent a discretionary sale.
• Filing timeliness: the filing does not indicate a late filing.

Why it may matter

• The filing indicates the sale was to satisfy tax withholding related to vesting of restricted stock units, and it states this was not a discretionary sale.
• A filing does not show why the insider traded or why the company acted.